Skip to main content

This is a preprint.

It has not yet been peer reviewed by a journal.

The National Library of Medicine is running a pilot to include preprints that result from research funded by NIH in PMC and PubMed.

Research Square logoLink to Research Square
[Preprint]. 2023 Apr 27:rs.3.rs-2832346. [Version 1] doi: 10.21203/rs.3.rs-2832346/v1

Longitudinal Analysis of the Impacts of Urogenital Schistosomiasis on the Gut microbiota of Adolescents in Nigeria

Olumide Ajibola 1, Swathi Penumutchu 2, Bashar Gulumbe 3, Uzairu Aminu 4, Peter Belenky 5
PMCID: PMC10168446  PMID: 37163079

Abstract

The gut microbiome is important for many host physiological processes and helminths and these interactions may lead to microbial changes. We carried out a longitudinal study of the impacts of S. haematobium infection on the gut microbiome of adolescents (11–15 years) in northern Nigeria pre and post praziquantel treatment. Using 16S sequencing a total of 267 DNA from faecal samples of infected versus uninfected adolescents were amplified and sequenced on an Illumina Miseq. We assessed the diversity of the taxa using alpha diversity metrices and observed that using Shannon index we obtained significant differences when we compared infected samples at 3, 9 and 12 months to baseline uninfected controls (P= <0.0001, P=0.0342 and P=0.0003 respectively). Microbial community composition analysis revealed that there were only significant differences at 3, 9 and 12 months (P=0.001, P=0.001, P=0.001 and P=0.001, respectively). We also demonstrated that the effects of the infection on the gut was more significant than praziquantel. Overall, our data suggests that S. haematobium, a non-gut resident parasite has indirect interactions with the gut. The bacterial taxa changes we have identified opens up the opportunity to investigate their role in human health, especially in urogenital schistosomiasis endemic communities.

Introduction

Schistosomiasis, also known as bilharzia, is prevalent in children due to lack of good hygiene practices, access to clean water, and poor health care facilities in affected countries such as Nigeria1. There are at least 240 million people infected annually worldwide, with 93% of those infected located in sub-Saharan Africa (SSA)2,3. Schistosomes have a complex life cycle involving humans, snails, and freshwater. There are three main species of Schistosoma that cause human schistosomiasis, S. mansoni, S. haematobium and S. japonicum4. In SSA, S. haematobium is the main causative agent of urogenital schistosomiasis5,6. Adult male and female schistosomes can be found in the veins of their human hosts, and schistosomula, a specific life cycle stage of the parasite can migrate through lymphatics and blood circulatory systems to the lungs and liver7. Ultimately, parasites reside within the perivascular or mesenteric venules. Fertilised eggs are shed in faeces or urine through the mating of adult male and female worms that arrive at the mesenteric veins of the lower plexus of the large intestine. Diagnosis of schistosomiasis is primarily through microscopic examinations of urine or faeces. Treatment is administered using praziquantel, and endemic countries engage in regular rounds of mass drug administration campaigns7,5,8.

The gut microbiome is important for many host physiological processes, including the development of the immune system and other systemic changes9,10. The microbiome of humans has been described to be associated with many communicable and non-communicable diseases. Helminths, have the ability to colonise the same environment as bacteria or have indirect systemic impacts on the gut and these interactions may lead to microbial changes in the gut11,12. Helminths have also been demonstrated to skew immune responses towards a T-helper 2 cell response and modulate the gut microbiome promoting the bloom in bacteria species such as Prevotella and Proteobacteia species13–15. Proteobacteria is seen as a marker of dysbiosis in the intestinal microbiome, as well as a critical determinant of host’s health, metabolism and inflammation16. Increases in Proteobacteria largely attributed to a bloom in Enterobacterales is associated with oxygen which contributes to microbiome and systemic inflammation which could affect infection prognosis17–21. In a recent study in Zimbabwe, Kay et al., reported differences in the microbiome structure of children infected with S. haematobium versus uninfected, with no reversal of the microbiome structure post praziquantel treatment. They also showed an abundance of Proteobacteria species in their infected cohorts14. Studies in Australia and Ecuador have also shown that helminth infections increased overall bacterial diversity in infected versus uninfected cohorts22,23.

In our previous work, we profiled the faecal microbiome of adolescents (ages 11 to 15 years) positive for S. haematobium versus uninfected controls. We demonstrated that the microbiomes of infected children differed dramatically from the uninfected group. Specifically, S. haematobium-positive subjects had more diverse microbiomes as measured by observed operational taxonomic units (OTUs). There was also a reduction in Firmicutes and an elevation in Proteobacteria which is a classic indication of microbiome dysbiosis. While this work is a strong indicator that S. haematobium is associated with microbiome differences it was lacking a longitudinal perspective or the impact of praziquantel therapy which may be required to establish the parasite as the cause of gut microbiome changes. There are limited studies from Africa that have examined the association between helminth infections and gut microbiome13. To understand the interaction of S. haematobium and the gut microbial community, we carried out a one-year longitudinal analysis of 267 stool samples of S. haematobium infection on the gut microbiome of adolescents (11–15 years) pre and post praziquantel treatment in Kebbi State, northwest Nigeria where urogenital schistosomiasis is endemic. We accounted for factors such as age, sex, diet, disease states, and other conditions that could influence the gut microbiome. Here, we describe the impacts of S. haematobium interactions with the gut microbiome on a longitudinal basis with samples collected at five time points.

Materials and Methods

Ethics Statement

This study was approved by the Kebbi State Ministry of Health, Nigeria registration number KSHREC 106:47/2021. All research was undertaken in accordance with the relevant guidelines and regulations of the Kebbi State Ministry of Health. The study and its risks were explained to the participants, who then verbally assented to participation if they were interested. Parents and or legal guardians of adolescents were requested to provide informed consent for their child’s participation by signing the study consent form; in the case of illiteracy, thumbprinting was used, as approved by the State Ministry of Health Ethics Committee.

To reduce the risk of co-infection with gastrointestinal helminths, any potential subjects who reported recent gastrointestinal distress were excluded. Prior to sample collection, the parents/guardians of adolescents who had consented to their children’s participation were informed of the study as well as any associated risks.

Study area

Sample collection

Stool and mid-stream urine samples were collected between 10 am and 2 pm in standard specimen collection bottles, labelled and transported to the laboratory for processing. The sedimentation technique was applied for examination of S. haematobium eggs in the urine. A minimum of 10 mL of urine was collected per participant at baseline and every three months. Urine was spun down at 1,000 × g for 5 minutes, the supernatant was decanted, and the sediments were examined under the 40x objective of a brightfield microscope (Olympus, USA) to identify S. haematobium eggs13. Stool samples were also collected from each child who provided a urine sample and stored in sterile bottles. All samples were frozen at − 20 °C within 3 hours of collection until DNA extraction. The presence of eggs in the urine was used to identify cases of adolescents with urogenital schistosomiasis. After sample collection, all the children were treated with 40 mg/kg praziquantel by the State government nurses as part of the bi-annual national schistosomiasis control program.

DNA extraction

Microbial DNA was extracted from a total of 267 stool samples of adolescents: 46 urogenital schistosomiasis-infected adolescents supplied stool samples at baseline, they were treated with praziquantel and followed for one year and supplied stool samples every three months (Supplementary Table 1). Fifty uninfected kids provided stool samples at baseline and only 18 of the 50 uninfected kids provided samples at six months post praziquantel treatment. All stool samples were transported to the laboratory and frozen at − 20 °C before DNA extraction. Approximately 1 g of stool was removed from the center of defrosted fecal samples and was processed following the manufacturer’s protocol using the Quick DNA Fecal/Soil Microbe MiniPrep ™ Kit ZR D6010 (Zymo Research), which utilizes robust mechanical lysis.

16S rRNA sequencing

16S Amplicon generation

Extracted genomic DNA was quantified using Qubit2 (Invitrogen) to ensure sufficient quantity for amplification. Amplification was carried out in triplicates using the Earth Microbiome Project protocols24 using a library of barcoded adaptor primers and a single reverse primer (806R) to amplify the V4 hypervariable region of the 16S rRNA gene with Phusion high-fidelity polymerase. The cycling conditions used for amplicon generation were as follows: (1) initial denaturation at 98°C for 30 s, (2) 34 cycles consisting of denaturation for 10 s at 98°C, annealing at 57°C for 30 s and extension at 72°C for 30 s, followed by a (3) final extension at 72°C for 5 min. Approximately 240 ng of each amplicon was pooled together for library generation.

Library generation

16S amplicons were cleaned using the NucleoSpin PCR Cleanup Kit (Machery-Nagel, Düren, Germany) before submission to the Rhode Island Genomics and Sequencing Center at the University of Rhode Island (Kingston, RI, USA). Samples were pair-end sequenced (2 × 250 bp) on the Illumina MiSeq platform using the 600-cycle kit with standard protocols.

Data processing

Analysis of 16S rRNA Sequencing Reads

Raw 16S rRNA reads were subjected to quality filtering, trimming, de-noising with DADA2 (via q2-dada2)25. Demultiplexed reads were imported into the software package Quantitative Insights Into Microbial Ecology 2 (QIIME2 version 2021.8)26. Within QIIME2, raw reads were quality-filtered, denoised and merged using the Divisive Amplicon Denoising Algorithm 2 (DADA2) pipeline25. Ribosomal sequence variants were aligned with mafft (via q2-alignment)27, and phylogenetic tree construction was done with fasttree2(via q2-phylogeny)28. Taxonomic assignment was conducted using the pre-trained Naive Bayes classifier and the q2-feature-classifier29 trained on the SILVA 132 99% database30. Taxonomy was assigned using the 99% identity SILVA (release 119) V4 classifier30. Amplicon sequence variants (ASVs) were generated through traditional clustering methods. The ASV table, rooted phylogenetic tree, representative sequences, and metadata from QIIME2 were then exported for further analysis in R (V3.3.1). Differential abundance testing was performed using the DESeq2 R package31. Microsoft Excel version 16.68 was used to rank the top 10 taxa from the ASV tables and graphs were plotted in Graphpad prism version 9.3.1.

Diversity Analyses

Alpha diversity (Shannon, Faith’s phylogenetic diversity) and beta diversity (Bray-Curtis dissimilarity)32,33 were calculated using the phyloseq package (version 1.30.0) in R (version 3.6.2)34–36, 37,38. Two-tailed Mann Whitney U test (Prism v9) was used to determine the significance of differences in alpha diversity between infection groups. Beta diversity (Bray-Curtis dissimilarity) was analysed using the VEGAN (V2.4-package39, and PERMANOVA was used to analyse the significance of differences in beta diversity using the adonis function in phyloseq(version #.#.#). Principal coordinate analysis (PCoA) was then performed on the beta diversity distance matrices to visualize any relationships between microbiome composition and infection status.

Differential Abundance Analyses

Differential abundance analysis between infection groups was performed using the DESeq2 (V1.14.1) package in R with agglomeration at various taxonomic levels31. Significance was determined by the Benjamini, Krieger and Yekutieli test to correct for False discoveries with adjusted p-value < 0.0540.

Results

Cohort characteristics: A total of 267 stool samples were collected over one year every three months at four-time points from 99 volunteers (46 urogenital schistosomiasis positive and 50 negative) aged between 11–15 years. There were 41 (89.1%) male and 5 female (10.9%) infected children analysed in this study (Supplementary Table 1). There were no significant differences in the dietary habits of the subjects in this study. All subjects at baseline provided urine and stool samples and were treated with praziquantel irrespective of their infection status as part of an ongoing bi-annual prophylaxis campaign for schistosomiasis. We were able to collect stool and urine samples from the infected subjects at baseline, 3, 6, 9 and 12 months, respectively. Some of the infected subjects were lost to follow up and the number of subjects that provided samples at each time point is shown in supplementary Table 1. While for uninfected adolescents, we collected samples at baseline and 6 months respectively.

Baseline composition of the microbiome

Previously, we have shown that there were differences in the gut microbiome of uninfected and infected kids at baseline. To ensure the robustness and reproducibility of our work, we re-analysed the sequences from 2017 using the current SILVA database30 and combined the sequences with sequences we generated in the current study for analysis. We began by investigating changes in community composition at higher taxonomic levels at baseline. Comparison of sequences from samples that were analysed in 2022 and re-analysed sequences from samples collected in 2017 were combined for analysis. Using excel we ranked the top 10 ASVs and found that a baseline comparison of the three groups revealed a state of dysbiosis as a result of increased Proteobacteria, Euryarchaeota and decrease in Firmicutes and Cyanobacteria (Fig. 1A). We also analysed the taxonomy at lower levels (Supplementary Figs. 1–2: class and order) and identified lineages that increased (Pediococcus, Faecalibacterium and Prevotella) and decreased (Sarcina, Rombutsia and Clostridium_Sensu stricto) (Fig. 1B-C).

Figure 1.

Figure 1.

1a. Differences in Relative abundance in Phyla at baseline.

1b. Differences in Relative abundance in Genera at baseline.

1c. Differences in relative abundance of Selected Genera at baseline selected from combined dataset (2017&2022).

Longitudinal Changes Across Taxonomic levels

Once we established that there were taxonomic changes in the microbiome of infected and uninfected kids at the Phylum and Genera levels, next, we decided to investigate these changes longitudinally over one year across family, order, and class. We decided to focus our analyses using the combined 16S sequences from 2017 and 2022. At baseline, we observed an increase in Prevotellaceae, Ruminococcaceae, Streptococcaceae, Methanobacteriaceae and Enterobacterales at the family level. Family level changes at 3 months were similar to baseline, with the exception of marked increases in Prevotellaceae and Ruminococcaceae relative abundances. Family level changes at 6 months were similar to those of baseline, with the exception that Anaerovoracaceae was significantly reduced and Prevotellaceae was completely absent in both infected and uninfected subjects. At 9 and 12 months, the microbiomes were very similar, with Anaerovoracaceae being restored to uninfected levels at baseline (Fig. 2A). At the order level, we observed that most members were reduced in the infected compared to the uninfected group, with the exception of the presence of Pseudomonadales, which was absent in the uninfected kids (Fig. 2B). At 3 months, the members had a different microbiome from baseline with enrichment of Bacterioidales, Lachnospirales and Oscillospirales. While at 6 months, the microbiome of infected and uninfected subjects was similar, by later timepoints (9 and 12 months) microbiomes remained similar between infected and uninfected groups, however these microbiomes were distinct from previous timepoints (0, 3 and 6 months). There was an enrichment of Oscillospirales, Lachnospirales and reduced levels of Clostridiales. At the class taxonomic level, the main difference was observed at 3 months with a marked increase in Bacteroidia compared to all other time points. Additionally, Methanobacteria was completely absent at 3, 9 and 12 months from the microbiome of the kids (Fig. 2C).

Figure 2.

Figure 2.

2a. Changes in Taxa across the timepoints at Family, order and class level

2b. Changes in Taxa across the timepoints in selected members in the order

2c. Changes in Taxa across the timepoints in selected class members

Differential abundance of Genera

We carried out differential abundance analysis of our samples at the genus level across all time points analysed in our study using DESeq231. We identified significant differences in 32 genera at baseline. Some of the genera that increased include Prevotella, Alloprevotella, UCG-005, Uncultured, Acinetobacter, Christensenellaceae, Treponema, Holdemanella, Megaspaera, Blautia, Bacteroides, Muribaculaceae, Faecalibacterium, Dialister and Catenibacterium and those that decreased were Lactobacillus 1 & 2, Pediococcus 1 & 2, Chloroplast and Weisella (Fig. 3). The significant changes in genera at 3 and 6 months were similar to baseline with the addition of an increase in Ruminococcus at 3 months. The following decreased genera at 3 months (Anaerococcus, Methanosphaera, Clostridium sensu stricto and Romboutsia) and 6 months (Finegoldia, Lactococcus, Lachnospiraceae NKA136, Clostridium sensu stricto, Anerosalibacter and Enterococcus) were present in addition to the changes observed at baseline. The differential abundances of the bacteria present at 9 and 12 months were similar (Fig. 3) compared to those from baseline to 6 months. We observed that there was more Prevotella species at 9 months and 12 months, irrespective of infection status, compared to other time points in our analysis.

Figure 3.

Figure 3.

Differential expression of genera

Longitudinal gut microbial alpha and beta diversity analyses between Infection groups

We examined the metrics of alpha diversity to determine the diversity of taxa within each microbial community across all the time points sampled. We used two different metrics for analysis; Shannon, and Faith’s Phylogenetic Diversity (Fig. 4). We conducted a comparison of all samples that had a corresponding uninfected control at the same time point, while those that didn’t have corresponding controls were compared to baseline uninfected controls. We observed that there were no significant differences for Shannon indices at baseline and 6 months between uninfected versus infected individuals (P = 0.7847, and P = 0.2632 respectively). However, when we compared infected samples at 3, 9 and 12 months to baseline uninfected controls we observed significant differences (P = < 0.0001, P = 0.0342 and P = 0.0003 respectively). Taxonomic richness of the microbial community measured using the amplicon sequence variants (ASVs) were not significant at baseline and 9 months (P = 0.5009 and P = 0.1408), while there were significant differences at 3, 6 and 12 months (P = 0.0076, P < 0.0001 and P = 0.0023). Faith’s phylogenetic diversity was also computed and found to be significantly different at 3, 6 and 12 months (P = 0.0221, P = 0.0001 and P = 0.0088), while there were no significant differences at baseline and 9 months (P = 0.4343 and P = 0.4297). Next, we examined the beta diversity of the samples to determine the divergence in community composition between the samples collected at the various time points. This was measured using the Bray Curtis similarity index, and PERMANOVA to test for statistical differences. We observed that there were no significant differences in the microbial community composition at baseline and 6 months (P = 0.1329 and P = 0.6533). While a comparison of the baseline composition of microbial community composition to time points 3, 9 and 12 months (P = 0.001, P = 0.001, P = 0.001 and P = 0.001, respectively) were significantly different (Fig. 5).

Figure 4.

Figure 4.

Measures of Alpha Diversity

Figure 5A-B.

Figure 5A-B.

Principal coordinate analysis of community similarity by schistosomiasis infection patterns. No Significant difference between infected versus uninfected adolescents

Effects of praziquantel on the gut microbiome

Following the differences observed in the microbial community composition at 3, 9 and 12 months, we asked whether these effects were as a result of the anthelminthic treatment given to the kids. To describe this, we used a DESEq analysis to determine the impact of the drug on the kids gut microbiomes across the various time points sampled. We observed that the effects of praziquantel on the gut microbiome of the subjects was minimal when compared to changes induced by the infection. In Fig. 6, it is clearly visible that the infected adolescents have more significant differences compared to praziquantel. Other analysis of other timepoints of the impacts of praziquantel revealed no significant impacts (Supplementary Fig. 3).

Figure 6.

Figure 6.

DESEq analysis for impact of praziquantel on the gut microbiome

Impact of praziquantel on the gut microbiome. (A) baseline versus 6-months negative. (B) baseline vs 6-months positive showing that infected adolescents have more significant effects than praziquantel.

Discussion

Studies on the microbiome have gained significant advances in the last decade and improved our understanding of various biological processes in the human body, identified new drug targets and treatment strategies. Here, we used 16S sequencing to investigate the longitudinal impacts of S. haematobium infection on the gut microbiome of adolescents in Nigeria. Several studies have described the impacts of age41,42, diet and the environment43,44 on the composition of the microbiome. Our findings are consistent with previous studies that schistosome infections have an impact on the diversity and abundance of the gut microbiome12–15, 22,45. In our previous work, we described signatures of dysbiosis in the gut of kids infected with urogenital schistosomiasis compared to uninfected kids at a single time point13. Here, we combined the sequences from our 2017 study and new longitudinal data from 2022 at five timepoints, reanalysed the data, and our analysis still revealed a gut microbiome that was reminiscent of a state of dysbiosis. The reduction in Firmicutes abundance was more in the 2017 sequences compared to the 2022 or the combined sequences from both years (2017 and 2022). Firmicutes have been positively associated with soil-transmitted helminth infections46. At the genus level, we observed baseline differences in Clostridium_sensu_stricto_1, Romboutsia, Sarcina, Prevotella and other genera that have been demonstrated to be important members of the gut microbiome47. Similar to previous studies, we also demonstrate that in addition to the reduction in Firmicutes abundance, a major difference at the Phyla level between S. haematobium infected and uninfected kids was an increase in Proteobacteria in the infected cohorts. Some of the bacterial taxa changes we observed at baseline were similar to published reports from Zimbabwe where 16S and metagenomic analysis were done on stool samples S. haematobium infected kids14,15.

We also describe the longitudinal impacts of S. haematobium infection over a period of one year at five-time points. Most studies on the impacts of helminths on the gut microbiome have been single time points or collected data pre and post-anthelminthic treatments. This presented a unique opportunity to investigate the temporal changes that may occur in the gut microbiome pre and post-praziquantel administration in the study population. In addition, it provided an opportunity to investigate the role of a non-gut resident parasite as the cause of the microbiome changes in these kids. The temporal analysis of the significant genera changes that increased across all the time points (baseline, 3, 6, 9 and 12 months) identified genera such as Acinetobacter, Treponema, Bacteroides, Alloprevotella and Prevotella as some of the key taxa that changed. While the key genera that significantly decreased across all time points were Pediococcus, Chloroplast, Lactobacillus and Weissella. Pediococcus species e.g. P. acidilactici has been associated with improving recovery from gastrointestinal disorders and a decrease in clinical severity of atopic dermatitis48,49. Weissella species have been isolated from raw milk, fermented cereals and vegetables50. Some species, such as W. cibaria, have been identified to possess anticancer, anti-inflammatory, anti-fungal, anti-bacterial and immune-boosting properties51,52. W. cibaria is a lactic acid bacterium and has been associated with regulating the integrity of the intestinal epithelial barrier, through dampening inflammatory responses that reduce the synthesis of TNFa, IL-6 and Il-851,52. The significant reduction in the presence of these bacteria in the S. haematobium infected group might point to increased inflammation in the kids. Some studies have described the association of certain bacteria taxa, such as Dialister, Clostridium XIVa, Weissella and Bacteroides with incomplete parasite clearance53.

The African diet is carbohydrate-rich, and some studies have described that Prevotella and Candida are associated with carbohydrate rich diets54. The kids in this study feed mostly on carbohydrate-rich foods such as fura da nono, rice and kunun zaki typical of northern Nigeria residents55. Indeed, we observed high Prevotella levels at baseline which increased significantly at later time points 9 and 12 months. The age group of the participants in this study was restricted to 11–15 years, this is important to note considering the variability associated with the microbiome structure of kids as they grow42,56,57. Our selection of this age group is based on our previous work, where we have demonstrated that there were no age-specific effects on the gut microbiome13. Owing to the peculiarity of our study population as previously reported, we could not control for possible sex-related bias, hence we had more males than females enrolled in this study. This is not unusual for a conservative Islamic population, where girls tend to be less willing to participate in studies of this nature. Previous studies have, however, reported that there were no sex-related bias on the impacts on helminth infections on the gut microbiome13,53. Within urogenital schistosomiasis endemic communities, several studies have reported that differences in infection patterns seen in gender is linked to increased water contact practices amongst males as opposed to females58,59. One of the limitations of this study was a loss to follow-up of some of the study subjects and the inability to collect samples from all uninfected kids at the time points that were analysed. This would have allowed more precise comparisons of the microbiomes as they change pre and post-praziquantel treatment over time. Another challenge with collecting uninfected samples from schistosome endemic communities is the likelihood of the kids having been infected in the past and being cured of the infection. However, we anticipated that the likelihood of the uninfected groups having obtained an infection within two years prior to the study was low. We make this assumption because there had been no mass drug administration campaign in the community for at least 2 years before our study, and all participants reported not to have taken any anthelminthic treatment within the same period.

One of the challenging aspects of microbiome research is inferring causation, especially in a community that is schistosome endemic, which we could not establish in this study. We observed significant differences in the microbial communities at 3, 9 and 12 months compared to baseline and 6 months. Further analysis revealed that infection seemed to have greater effect on the changes on the gut than praziquantel. The changes in the microbiome of adolescents could also due to declining efficacy of the drug or normal changes associated with adolescents as they grow. It is interesting to observe that S. haematobium worms mostly live in the pelvis venous plexus60, yet they exert indirect effects on the gut microbiome just like other intestinal helminths22,45,47, 61–66. The changes in the microbial composition of the gut through the activity of helminths have led to the hypothesis that there is a potential link between these microbial community changes and the modulation of inflammatory responses in autoimmune diseases.

In conclusion, the strength of our study is in its design and the opportunity provided to examine the dynamic relationship of the parasite with the host pre and post-anthelminthic treatment over a period of one year. It also allowed us to study the microbial community differences and any dietary or environmentally related changes that occurred in the subjects over time, specifically at later time points. To the best of our knowledge, this is the first study to investigate the longitudinal impacts of S. haematobium on the gut microbiome, these findings open up opportunities for future studies to examine the impacts of the bacteria taxa changes we have described in this study and its implication for human health.

Supplementary Material

Supplement 1

Figure 5C-F.

Figure 5C-F.

Significant differences between baseline positive patients over time

Acknowledgements

The authors thank all participants in the study, their parents, the Kebbi State Ministry of Health and Argungu General Hospital for their support.

Funding

This research was supported by the National Institute of Diabetes and Digestive and Kidney Disease of the National Institutes of Health (R01DK125382). OA was a Career Development Fellow and this study is part of the EDCTP2 programme supported by the European Union (TMA2019CDF-2762-SiDIC). S.P was supported by the National Science Foundation Graduate Research Fellowship (1644760).The funding agencies had no role in the study design, data collection, analysis, or interpretation. The opinions and interpretations presented here are not representative of the standing of the funding agencies.

Footnotes

Declarations

Data availability

The datasets used and/or analysed during the current study are available from the corresponding author(s) on reasonable request.

Conflict of Interest

Authors do not have any conflict of interest to declare.

Contributor Information

Olumide Ajibola, First Technical University.

Swathi Penumutchu, Brown University.

Bashar Gulumbe, Federal University Birnin Kebbi.

Uzairu Aminu, Federal University Birnin Kebbi.

Peter Belenky, Brown University.

References

  • 1.Libertucci J. & Young V. B. The role of the microbiota in infectious diseases. Nat. Microbiol. 4, 35–45 (2019). [DOI] [PubMed] [Google Scholar]
  • 2.World Health Organisation. World Health Organisation Schistosomiasis (Bilharzia). World Health Organization. 2021. https://www.who.int/health-topics/schistosomiasis#tab=tab_1. [Google Scholar]
  • 3.Gryseels B., Polman K., Clerinx J. & Kestens L. Human schistosomiasis. Lancet Lond. Engl. 368, 1106–1118 (2006). [DOI] [PubMed] [Google Scholar]
  • 4.Chuah C., Gobert G. N., Latif B., Heo C. C. & Leow C. Y. Schistosomiasis in Malaysia: A review. Acta Trop. 190, 137–143 (2019). [DOI] [PubMed] [Google Scholar]
  • 5.Gray D. J., Ross A. G., Li Y.-S. & McManus D. P. Diagnosis and management of schistosomiasis. The BMJ 342, (2011). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.World Health Organization. Schistosomiasis. (2019).
  • 7.Colley D. G., Bustinduy A. L., Secor W. E. & King C. H. Human schistosomiasis. Lancet Lond. Engl. 383, 2253–2264 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Hinz R., Schwarz N. G., Hahn A. & Frickmann H. Serological approaches for the diagnosis of schistosomiasis - A review. Mol. Cell. Probes 31, 2–21 (2017). [DOI] [PubMed] [Google Scholar]
  • 9.Shi N., Li N., Duan X. & Niu H. Interaction between the gut microbiome and mucosal immune system. Mil. Med. Res. 4, 14 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.König J. et al. Human Intestinal Barrier Function in Health and Disease Clin. Transl. Gastroenterol. 7, e196 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Stensvold C. R. & van der Giezen M. Associations between Gut Microbiota and Common Luminal Intestinal Parasites. Trends Parasitol. 34, 369–377 (2018). [DOI] [PubMed] [Google Scholar]
  • 12.Pereira de Araújo M. et al. Unbalanced relationships: insights into the interaction between gut microbiota, geohelminths, and schistosomiasis. PeerJ 10, e13401 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Ajibola O. et al. Urogenital schistosomiasis is associated with signatures of microbiome dysbiosis in Nigerian adolescents. Sci. Rep. 9, 829 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Kay G. L. et al. Differences in the Faecal Microbiome in Schistosoma haematobium Infected Children vs. Uninfected Children. PLoS Negl. Trop. Dis. 9, e0003861 (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Osakunor D. N. M. et al. The gut microbiome but not the resistome is associated with urogenital schistosomiasis in preschool-aged children. Commun. Biol. 3, 155 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Shin N.-R., Whon T. W. & Bae J.-W. Proteobacteria: microbial signature of dysbiosis in gut microbiota. Trends Biotechnol. 33, 496–503 (2015). [DOI] [PubMed] [Google Scholar]
  • 17.Scales B. S., Dickson R. P. & Huffnagle G. B. A tale of two sites: how inflammation can reshape the microbiomes of the gut and lungs. J. Leukoc. Biol. 100, 943–950 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18.Gophna U., Sommerfeld K., Gophna S., Doolittle W. F. & Veldhuyzen van Zanten S. J. O. Differences between Tissue-Associated Intestinal Microfloras of Patients with Crohn’s Disease and Ulcerative Colitis. J. Clin. Microbiol. 44, 4136–4141 (2006). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19.Lupp C. et al. Host-Mediated Inflammation Disrupts the Intestinal Microbiota and Promotes the Overgrowth of Enterobacteriaceae. Cell Host Microbe 2, 119–129 (2007). [DOI] [PubMed] [Google Scholar]
  • 20.Wang M., Molin G., Ahrné S., Adawi D. & Jeppsson B. High Proportions of Proinflammatory Bacteria on the Colonic Mucosa in a Young Patient with Ulcerative Colitis as Revealed by Cloning and Sequencing of 16S rRNA Genes. Dig. Dis. Sci. 52, 620–627 (2007). [DOI] [PubMed] [Google Scholar]
  • 21.Mukhopadhya I., Hansen R., El-Omar E. M. & Hold G. L. IBD—what role do Proteobacteria play? Nat. Rev. Gastroenterol. Hepatol. 9, 219–230 (2012). [DOI] [PubMed] [Google Scholar]
  • 22.Lee S. C. et al. Helminth Colonization Is Associated with Increased Diversity of the Gut Microbiota. PLoS Negl. Trop. Dis. 8, e2880 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Cantacessi C. et al. Impact of Experimental Hookworm Infection on the Human Gut Microbiota. J. Infect. Dis. 210, 1431–1434 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.The Earth Microbiome Project Consortium et al. A communal catalogue reveals Earth’s multiscale microbial diversity. Nature 551, 457–463 (2017). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Callahan B. J. et al. DADA2: High-resolution sample inference from Illumina amplicon data. Nat. Methods 13, 581–583 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Bolyen E. et al. Reproducible, interactive, scalable and extensible microbiome data science using QIIME 2. Nat. Biotechnol. 37, 852–857 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Katoh K. MAFFT: a novel method for rapid multiple sequence alignment based on fast Fourier transform. Nucleic Acids Res. 30, 3059–3066 (2002). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Price M. N., Dehal P. S. & Arkin A. P. FastTree 2 – Approximately Maximum-Likelihood Trees for Large Alignments. PLoS ONE 5, e9490 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Bokulich N. A. et al. q2-longitudinal: Longitudinal and Paired-Sample Analyses of Microbiome Data. mSystems 3, e00219–18 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Quast C. et al. The SILVA ribosomal RNA gene database project: improved data processing and web-based tools. Nucleic Acids Res. 41, D590–D596 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Love M. I., Huber W. & Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15, 550 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Bray J. R. & Curtis J. T. An Ordination of the Upland Forest Communities of Southern Wisconsin. Ecol. Monogr. 27, 325–349 (1957). [Google Scholar]
  • 33.Bokulich N. A. et al. Optimizing taxonomic classification of marker-gene amplicon sequences with QIIME 2’s q2-feature-classifier plugin. Microbiome 6, 90 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Faith D. P. Conservation evaluation and phylogenetic diversity. Biol. Conserv. 61, 1–10 (1992). [Google Scholar]
  • 35.Lozupone C. & Knight R. UniFrac: a New Phylogenetic Method for Comparing Microbial Communities. Appl. Environ. Microbiol. 71, 8228–8235 (2005). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Lozupone C. A., Hamady M., Kelley S. T. & Knight R. Quantitative and Qualitative β Diversity Measures Lead to Different Insights into Factors That Structure Microbial Communities. Appl. Environ. Microbiol. 73, 1576–1585 (2007). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.McMurdie P. J. & Holmes S. Phyloseq: a bioconductor package for handling and analysis of high-throughput phylogenetic sequence data. Pac. Symp. Biocomput. Pac. Symp. Biocomput. 235–246 (2012). [PMC free article] [PubMed]
  • 38.McMurdie P. J. & Holmes S. phyloseq: An R Package for Reproducible Interactive Analysis and Graphics of Microbiome Census Data. PLoS ONE 8, e61217 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39.Dixon P. VEGAN, a package of R functions for community ecology. J. Veg. Sci. 14, 927–930 (2003). [Google Scholar]
  • 40.Benjamini Y. & Hochberg Y. Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing. J. R. Stat. Soc. Ser. B Methodol. 57, 289–300 (1995). [Google Scholar]
  • 41.Rodríguez J. M. et al. The composition of the gut microbiota throughout life, with an emphasis on early life. Microb. Ecol. Health Dis. 26, (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Yatsunenko T. et al. Human gut microbiome viewed across age and geography. Nature 486, 222–227 (2012). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43.De Filippo C. et al. Impact of diet in shaping gut microbiota revealed by a comparative study in children from Europe and rural Africa. Proc. Natl. Acad. Sci. 107, 14691–14696 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44.Fan W., Huo G., Li X., Yang L. & Duan C. Impact of Diet in Shaping Gut Microbiota Revealed by a Comparative Study in Infants During the Six Months of Life. J. Microbiol. Biotechnol. 24, 133–143 (2014). [DOI] [PubMed] [Google Scholar]
  • 45.Ramanan D. et al. Helminth infection promotes colonization resistance via type 2 immunity. Science 352, 608–612 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46.Martin I. et al. The Effect of Gut Microbiome Composition on Human Immune Responses: An Exploration of Interference by Helminth Infections. Front. Genet. 10, 1028 (2019). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 47.Schneeberger P. H. H. et al. Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome. Parasit. Vectors 11, 168 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48.Kim W.-S. et al. A new way of producing pediocin in Pediococcus acidilactici through intracellular stimulation by internalized inulin nanoparticles. Sci. Rep. 8, 5878 (2018). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Jeong D.-Y. et al. Pediococcus acidilactici intake decreases the clinical severity of atopic dermatitis along with increasing mucin production and improving the gut microbiome in Nc/Nga mice. Biomed. Pharmacother. 129, 110488 (2020). [DOI] [PubMed] [Google Scholar]
  • 50.Kamboj K., Vasquez A. & Balada-Llasat J.-M. Identification and significance of Weissella species infections. Front. Microbiol. 6, (2015). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Park H.-E. & Lee W.-K. Immune enhancing effects of Weissella cibaria JW15 on BALB/c mice immunosuppressed by cyclophosphamide. J. Funct. Foods 49, 518–525 (2018). [Google Scholar]
  • 52.Kim M., You Y., Kang J., Kim H. & Kang M. Weissella cibaria CMU exerts an anti–inflammatory effect by inhibiting Aggregatibacter actinomycetemcomitans–induced NF–κB activation in macrophages. Mol. Med. Rep. (2020) doi: 10.3892/mmr.2020.11512. [DOI] [PMC free article] [PubMed]
  • 53.Kupritz J., Angelova A., Nutman T. B. & Gazzinelli-Guimaraes P. H. Helminth-Induced Human Gastrointestinal Dysbiosis: a Systematic Review and Meta-Analysis Reveals Insights into Altered Taxon Diversity and Microbial Gradient Collapse. mBio 12, e02890–21 (2021). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54.Gorvitovskaia A., Holmes S. P. & Huse S. M. Interpreting Prevotella and Bacteroides as biomarkers of diet and lifestyle. Microbiome 4, 15 (2016). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55.Efiuvwevwere B. J. O. & Akona O. The microbiology of ?kunun-zaki?, a cereal beverage from northern Nigeria, during the fermentation (production) process. World J. Microbiol. Biotechnol. 11, 491–493 (1995). [DOI] [PubMed] [Google Scholar]
  • 56.Roswall J. et al. Developmental trajectory of the healthy human gut microbiota during the first 5 years of life. Cell Host Microbe 29, 765–776.e3 (2021). [DOI] [PubMed] [Google Scholar]
  • 57.Wernroth M.-L. et al. Development of gut microbiota during the first 2 years of life. Sci. Rep. 12, 9080 (2022). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Mafiana C. F., Ekpo U. F. & Ojo D. A. Urinary schistosomiasis in preschool children in settlements around Oyan Reservoir in Ogun State, Nigeria: implications for control. Trop. Med. Int. Health 8, 78–82 (2003). [DOI] [PubMed] [Google Scholar]
  • 59.Ekpo U. F., Laja-Deile A., Oluwole A. S., Sam-Wobo S. O. & Mafiana C. F. Urinary schistosomiasis among preschool children in a rural community near Abeokuta, Nigeria. Parasit. Vectors 3, 58 (2010). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60.Elwi A. M., Cheever A. W., Mosimann J. E., Kamel I. A. & Danner R. Schistosoma Mansoni and S. Haematobium Infections in Egypt: II. Quantitative Parasitological Findings at Necropsy*. Am. J. Trop. Med. Hyg. 26, 702–716 (1977). [DOI] [PubMed] [Google Scholar]
  • 61.Schachter J. et al. Whipworm Infection Promotes Bacterial Invasion, Intestinal Microbiota Imbalance, and Cellular Immunomodulation. Infect. Immun. 88, e00642–19 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Cooper P. et al. Patent Human Infections with the Whipworm, Trichuris trichiura, Are Not Associated with Alterations in the Faecal Microbiota. PLoS ONE 8, e76573 (2013). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Cortés A. et al. Baseline Gut Microbiota Composition Is Associated With Schistosoma mansoni Infection Burden in Rodent Models. Front. Immunol. 11, 593838 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Gordon C. A. et al. Helminths, polyparasitism, and the gut microbiome in the Philippines. Int. J. Parasitol. 50, 217–225 (2020). [DOI] [PubMed] [Google Scholar]
  • 65.Cantacessi C. et al. Impact of Experimental Hookworm Infection on the Human Gut Microbiota. J. Infect. Dis. 210, 1431–1434 (2014). [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66.Hu Y. et al. Alterations of Gut Microbiome and Metabolite Profiling in Mice Infected by Schistosoma japonicum. Front. Immunol. 11, 569727 (2020). [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplement 1

Articles from Research Square are provided here courtesy of American Journal Experts

RESOURCES